FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to system for programmed in space and time delivery of pharmaceutically active agent. In case of per oral introduction system is held in gastric part during prolonged time period. System contains core, one or more core-covering polymer layers, and preliminarily prepared empty space. Pharmaceutically active agent is in core or any of system layers, or both in core and in any of system layers. Invention also related to method of system obtaining. System of delivery in accordance with the invention is universal in type of pharmaceutically active agent, which is included into it.
EFFECT: system can be obtained on wide scale, does not require complex equipment and uses ordinary raw materials, which are biodegradable, non-toxic and biologically compatible.
32 cl, 10 dwg, 14 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICINE DELIVERY REGULATED SYSTEM CONTAINED IN STOMACH | 2002 |
|
RU2325152C2 |
NIMESULIDE-CONTAINING SUSTAINED-RELEASE COMPOSITIONS | 2000 |
|
RU2238087C2 |
PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2138251C1 |
MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES | 2005 |
|
RU2359678C2 |
CONTROLLED-RELEASE PHARMACEUTICAL TABLET FOR ORAL ADMINISTRATION METHODS FOR PREPARATION THEREOF | 2011 |
|
RU2603469C2 |
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
FILM-COVERED TABLET OF IMPROVED SAFETY FOR UPPER DEPARTMENTS OF GASTROINTESTINAL TRACT | 1998 |
|
RU2193880C2 |
METHODS OF TREATING GASTROINTESTINAL TRACT DISORDERS INDEPENDENTLY ON FOOD CONSUMPTION | 2014 |
|
RU2563993C1 |
DOSAGE FORMS OF RISEDRONATE | 2005 |
|
RU2381791C2 |
pH-CONTROLLED PULSE DELIVERY SYSTEMS, METHODS FOR PRODUCING AND USING THEREOF | 2005 |
|
RU2412694C2 |
Authors
Dates
2011-06-10—Published
2007-09-03—Filed